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Available online 2 September 2016Toxocara spp. are zoonotic parasites with global distribution infecting humans by incidental ingestions of eggs
shed in feces of dogs or cats. High seroprevalences have been reported from several regions of Africa, however
data from the Central African region remain limited. Although several clinical entities caused by larvae of
Toxocara spp. have been described, the public heath impact of this infection has so far often been neglected.
This study was conducted to estimate the prevalence in a rural central African population.
The population based studywas performed in volunteers in a rural region of Gabon. A two-step testing approach
was applied using an ELISA as screening test and a Western Blot (immunoblot) as conﬁrmatory assay. Basic de-
mographic data and risk factors were collected and compared between seropositive and negative participants.
In total, 199 out of 332 serum samples were tested positive for Toxocara spp. antibodies (59.9%). After standard-
ization for age to the overall Gabonese population seroprevalence was 53.6% (95% CI 48.2–59.0%). There was a
trend towards higher seroprevalence in participants with agricultural activity.
Seroprevalence of antibodies against Toxocara spp. is high in this rural population in Gabon. These results are
comparablewith previous reports from other sub-regions of Africa and add to our understanding of the epidemi-
ology of toxocariasis in Africa. Given the high prevalence of toxocariasis in tropical regions, it may be speculated
that clinically relevant presentations (e.g. visceral or ocular larva migrans syndrome) may occur in considerable
numbers. A formal assessment of the burden of disease and the public health impact of human toxocariasis is
therefore warranted.






Larva migrans visceralisHuman toxocariasis is a zoonotic infection caused by Toxocara canis
and Toxocara cati. Transmission occurs by accidental ingestion of eggs
shed via the feces of canids and felines. Puppies shed particularly high
numbers of eggs, which become infective only after several weeks of
maturation [1,2]. In humans, larvae may migrate to different tissues
and cause clinical symptoms after ingestion. Although most infections
are considered as self-limiting and are therefore usually not diagnosed,
several clinically distinct entities are described. The visceral larva
migrans syndrome (VLM) is mediated by the host's immune response
to themigration of larvae through different tissues, and is characterized
by common symptoms such as fever, abdominal pain, fatigue andmany
other unspeciﬁc symptoms [3]. The ocular larva migrans syndromedizin, Universität Tübingen,
ingen.de (M. Ramharter).
land Ltd. This is an open access articl(OLM) characterizes the migration of a larva into the eye which may
lead to irreversible visual impairment or blindness. “Covert
toxocariasis” is deﬁned as subclinical infection with Toxocara spp. and
usually shows only very mild symptoms if at all, most likely accounting
for the majority of cases. Migration of the larvae to the central nervous
system may evoke “neurotoxocariasis” leading to a broad spectrum of
neurologic symptoms such as paresis, epilepsy, headache and many
more depending on the exact locus of inﬂammation [4]. In addition, a
further syndromewith cardiac involvementhas been described recently
[5]. The disease is characterized by a virtually global distribution with
particularly high prevalences reported from poor, tropical regions of
the world and socioeconomically disadvantaged populations, where
lack of hygiene, warm climate and uncontrolled dog populations con-
tribute to favorable transmission conditions [1,6]. Previous reports
from other African sub-regions showed very high seroprevalence rates
with 45% in schoolchildren in Swaziland or 93% in a population in Lae under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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rica in general, epidemiologic data on human toxocariasis are non-
existing. However, it is known that the prevalence of other helminthic
infections that share certain epidemiologic risk factors is high [9,10]. Al-
though most infections with Toxocara spp. are indolent, the worldwide
occurrence and enormous number of cases may lead to a high number
of absolute cases with clinically relevant symptoms (intestinal disor-
ders, fatigue, blindness, epilepsy, cardiac involvement, etc.). Thus, the
disease might be of higher public health importance than previously
thought and is regarded by some experts as a global health problem
with considerable impact [11]. This study was performed to provide
ﬁrst prevalence data for toxocariasis in Gabon, which may serve as a
sentinel region for Central Africa.
For this cross-sectional survey volunteers of at least 18 years old
were included after obtaining written informed consent. Participants
were recruited from a random sample of villages in the province of
Moyen-Ogooué, Gabon. Gabon is a Central African country bordered
by the Republic of Congo, Equatorial Guinea, Cameroon and the Atlantic
Ocean with a tropical rainforest climate. The country ranks 110 out of
188 countries in the United Nations Human Development Index 2015
[12]. For recruitment community leaders were contacted and the entire
population was invited to participate. Study procedures were explained
in front of the whole community and each volunteer individually re-
ceived the opportunity to ask questions and discuss the procedures be-
fore written informed consent was obtained. For illiterate patients,
informed consent was documented by a ﬁngerprint and the signature
of an impartialwitness. The studywas approvedby the local ethics com-
mittee of the Centre de RecherchesMédicales de Lambaréné at the com-
pound of the Albert-Schweitzer Hospital in Lambaréné, Gabon (Ref 006/
2013). Serumwas obtained after centrifugation of blood sampled by ve-
nipuncture. All samples were tested with a commercially available en-
zyme-linked immunosorbent assay (ELISA) obtained from Bordier
Afﬁnity Products [13] following the manufacturer's instructions. Cut-
off absorbance was determined for each session and samples that lay
within a 5% (+/‐2.5%) margin of the cut-off absorbance were classiﬁed
as borderline. Positive and borderline samples subsequently underwent
testing for IgG antibodieswithWestern Blot (WB) using a commercially
available kit (LDBIO Diagnostics – Toxocara IgG WB) following the
manufacturer's instructions. Samples with unclear results were tested
again by an in-houseWB [14,15]. For demographic data and risk factors,
a questionnaire was completed. Besides basic demographic data such as
age, sex, number of persons in household and village, recorded data in-
cluded agricultural activity, ownership of dog, ownership of cat, hunting
activity, cultivation of vegetables and leisure activities in the forest. For
standardization, the age structure of the Gabonese population reported
in the 2014 revision of the U.N. World Population Prospects was used
[16]. IBMN® SPSS® Statistics Version 22 was used for statistical analy-
ses. A p-value of 0.05 or smaller was considered as statistically
signiﬁcant.
In total, serum samples of 332 participants from 16 communities
were analyzed in this study. 187 patients (56.3%) were female and
145 male (43.7%). Median age of the study population was 55 years
(25th–75th percentile 43–70 years) (see Table 1).Table 1
Age and sex characteristics of participants.
Characteristic n (%)
Age
18–39 years 64 (19.3%)
40–59 years 122 (36.7%)
60–79 years 111 (33.4%)




Female 187 (56.3%)In the ELISA, 193 (59.8%) serum samples were positive and 6 (1.9%)
samples were classiﬁed as borderline. In the conﬁrmatory analysis via
WB, 197 (99.0% of samples undergoing conﬁrmatory testing) samples
were positive in the ﬁrst round and two samples (1.0%) were classiﬁed
as not determinable; both samples were tested positive in the in-house
WB for Toxocara speciﬁc antibodies. Thus, in total a seroprevalence of
59.9% in the study population was found. Seroprevalence was higher
in women than in men with 116/187 (62.0%) and 83/145 (57.2%), but
there was no statistically signiﬁcant difference (p = 0.38). Direct stan-
dardization to the overall Gabonese population resulted in a seropreva-
lence of 53.6% (95% CI 48.2–59.0).
Assessing risk factors for their associationwith seroprevalence of an-
tibodies against Toxocara infections showed a trend towards higher
rates in individuals with agricultural activity (OR 1.64, 95% CI 0.94–
2.88; p = 0.083). The same was observed for patients cultivating vege-
tables (OR 1.55, 95% CI 0.90–2.65; p= 0.110). There was no statistically
signiﬁcant difference in the odds of “owning a dog” (OR 1.31, 95% CI
0.84–2.04; p = 0.233) “owning a cat” (OR 1.25, 95% CI 0.78–2.01;
p= 0.354)), “hunting” (OR 1.44 95% CI 0.82–2.51; p= 0.200) or “activ-
ities in the forest” (OR 1.40, 95% CI 0.84–2.32; p = 0.195) (see Table 2).
The present study reports a high seroprevalence (59.9%) of Toxocara
antibodies in a rural population of adults in Gabon, Central Africa. To
date data on the seroprevalence of Toxocara infections in Central Africa
are scarce. Whereas these rates are considerably higher than for many
Western populations, comparable seroprevalences were reported for
other sub-Saharan African regions [7,8,17,18]. These data indicate that
human Toxocara infections and toxocariasis is common andwidespread
in most of sub-Saharan Africa.
In a risk factor analysis there was a trend towards higher odds ratios
for toxocariasis in patients regularly involved in agricultural activity and
growing vegetables. This ﬁnding seems highly plausiblewhen consider-
ing that infection occurs through accidental ingestion of eggs via con-
taminated soil. Surprisingly, dog or cat ownership was not associated
with seropositivity in this study population. However, earlier reports
demonstrated that the age of the dog wasmore important than owner-
ship in itself [18], and other reports have not reproduced this associa-
tion [17]. In our study area, virtually all dogs are allowed to roam free
in the village andmay therefore contaminate thewhole village environ-
ment. This may also explain why ownership was not associated with
seropositivity.
Human toxocariasis is often considered as an indolent infectionwith
no or very little burden of disease besides cases of neurotoxocariasis and
ocular toxocariasis, which are reported worldwide [19,20]. However, in
a meta-analysis of case-control studies on the association between epi-
lepsy and seropositivity, a clear association was found with an OR of
1.92 (95% CI 1.50–2.44) [21]. Another meta-analysis assessed the link
between asthma and Toxocara spp. seropositivity and found an even
stronger association with an OR of 3.36 (95% CI 1.76–6.42) [22], al-
though this is discussed controversially. Yet another study postulated
that children with Toxocara antibodies had signiﬁcantly lower school
grades at the end of the year compared to seronegative controls [23].
This indicates that Toxocara infections may lead to a considerable num-
ber of patients with a severe disease in high prevalence settings.
Several limitations of this study need to be addressed. Firstly, the age
structure of the study population with a high number of relatively old
individuals is representative of the population structure of rural villages,Table 2
Risk factors for seropositivity against Toxocara.
Risk factor Odds ratio (95% CI) p-Value
Agricultural activity 1.64 (0.94–2.88) 0.083
Cultivating vegetables 1.55 (0.90–2.65) 0.110
Owning a dog 1.31 (0.84–2.04) 0.233
Owning a cat 1.25 (0.78–2.01) 0.354
Hunting 1.44 (0.82–2.51) 0.200
Activities in the forest 1.40 (0.84–2.32) 0.195
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were more likely to be missed due to absence because of work during
study visits. Serologic testingmay be prone to problems of low speciﬁc-
ity in settings of high co-endemicity of other parasitic infections. To ad-
dress this potential limitation a more speciﬁc conﬁrmatory Western
Blot test was performed for all samples tested positive in ELISA.
In summary, our study demonstrates a high seroprevalence of anti-
bodies against Toxocara spp. in this Central African adult population.
Toxocariasis is known to cause important clinical disease in a small pro-
portion of infected persons presenting as ocular, visceral or neurologic
toxocariasis. Based on this knowledge and the high prevalence in Cen-
tral Africa, it may therefore be speculated that toxocariasis poses a con-
siderable public health issue in affected communities. A systematic
assessment of toxocariasis is therefore warranted for high prevalence
regions of Sub-Saharan Africa.
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